Extracorporeal membrane oxygenation in the context of the 2009 H1N1 influenza a pandemic

Surgical Infections

Volumn 12, Issue 2, 2011, Pages 151-158

  Sihler, Kristen C ^a,b   Park, Pauline K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; SIALIDASE;

COUGHING; EXTRACORPOREAL OXYGENATION; FEVER; HUMAN; IMMUNE RESPONSE; INCUBATION TIME; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SURVIVAL RATE;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; RESPIRATORY INSUFFICIENCY;

EID: 79955782033     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2010.082     Document Type: Review

References (72)

1. Centers for Disease Control and Prevention. Update: influenza activity-United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:369-374.
2. Centers for Disease Control and Prevention. Swine Influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58: 400-402.
3. Centers for Disease Control and Prevention. Update: Infections with a swine-origin influenza A (H1N1) virus-United States and other countries, April 28, 2009. MMWR Morb Mortal Wkly Rep 2009;58:431-433.
4. Centers for Disease Control and Prevention. Update: novel influenza A (H1N1) virus infections-Worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep 2009;58:453-458.
5. Smith GJ, Vijaykrishna D, Bahl J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009;459:1122-1125.
6. Childs RA, Palma AS, Wharton S, et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 2009; 27:797-799.
7. Shinya K, Ebina M, Yamada S, et al. Avian flu: Influenza virus receptors in the human airway. Nature 2006;440: 435-436.
8. Chan MC, Chan RW, Yu WC, et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 2010;176:1828-180.
9. Maines TR, Jayaraman A, Belser JA, et al. Transmission and pathogenesis of swine-origin 2009A (H1N1) influenza viruses in ferrets and mice. Science 2009;325:484-748.
10. Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Sixth edition. Philadelphia. Elsevier Churchill Livingstone. 2005.
11. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis 2006;12:9-14. (Pubitemid 43143528)
12. Centers for Disease Control and Prevention. Serum crossreactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:521-524.
13. Hancock K, Veguilla V, Lu X. et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-1952.
14. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708-1719.
15. Cauchemez S, Donnelly CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009;361:2619-2627.
16. Lessler J, Reich NG, Cummings DA, et al. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med 2009;361:2628-2636.
17. Yang Y, Sugimoto JD, Halloran ME, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009;326:729-733.
18. Cao B, Li X-W, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361:2507-2517.
19. Crum-Cianflone NF, Blair PJ, Faix D, et al. Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infect Dis 2009;49:1801-1810.
20. Witkop CT, Duffy MR, Macias EA, et al. Novel influenza A (H1N1) outbreak at the U.S. Air Force Academy: Epidemiology and viral shedding duration. Am J Prevent Med 2010;38: 121-126.
21. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615.
22. Human infection with new influenza A (H1N1) virus: Clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009;84:185-189.
23. Clinical management of human infection with pandemic (H1N1) 2009: Revised guidance. Geneva. World Health Organization. November 2009. Available at www.who.int/ csr/resources/publications/swineflu/clinical-management/ en/index.html. Accessed August 24, 2010.
24. Fleury H, Burrel S, Balick Weber C, et al. Prolonged shedding of influenza A (H1N1) virus: Two case reports from France 2009. Eur Surveill 2009;14:19434.
25. Blyth CC, Iredell JR, Dwyer DE. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;361:2493.
26. Hui DS, Lee N, Chan PKS. Clinical management of pandemic 2009 influenza A (H1N1) infection. Chest 2010;137:916-925.
27. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009;460:1021-1025.
28. World Health Organization Recommended Use of Antivirals. Pandemic (H1N1 2009 briefing note 8. Available at www.who.int/csr/disease/swineflu/notes/h1n1- use-antivirals- 20090820/en/index.html. Accessed August 25, 2010.
29. World Health Organization. Clinical management of human infection with pandemic (H1N1 2009 revised guidance. Available at www.who.int/csr/resources/ publications/swineflu/ clinical-management-h1n1.pdf. Accessed August 25, 2010.
30. Kidd IM, Down J, Nastouli E, et al. H1N1 pneumonitis treated with intravenous zanamivir. Lancet 2009;374:1036.
31. Gaur AH, Bagga B, Barman S, et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med 2010;362:88-89.
32. Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010. Wkly Epidemiol Rec 2009;85:37-40.
33. Centers for Disease Control and Prevention (CDC). Interim guidance on case definitions to be used for investigations of novel influenza A (H1N1) cases. Available at www.dphss .guam.gov/docs/swine-flu/H1N1-Guidance/ case%20def%20 june%201.pdf. Accessed August 24, 2010.
34. Dawood FS, Hope KG, Durrheim DN, et al. Estimating the disease burden of pandemic (H1N1) 2009 virus infection in Hunter New England, Northern New South Wales, Australia, 2009. PLoS One 2010;5:e9880.
35. Grills N, Piers LS, Barr I, et al. A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009. Aust NZ J Public Health 2010;34:228-231.
36. Gurav YK, Pawar SD, Chadha MS, et al. Pandemic influenza A (H1N1) 2009 outbreak in a residential school at Panchgani, Maharashtra, India. Indian J Med Res 2010;132:67-71.
37. World Health Organization. Epidemiological summary of pandemic influenza A (H1N1) 2009 virus-Ontario, Canada, June 2009. Wkly Epidemiol Rec 2009;84:485-491.
38. France AM, Jackson M, Schrag S, et al. Household transmission of 2009 influenza A (H1N1) virus after a schoolbased outbreak in New York City, April-May 2009. J Infect Dis 2010;201:984-992.
39. Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 2009;84:481-484.
40. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009;302:1896-1902.
41. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-1944.
42. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302:1880-1887.
43. The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-1934.
44. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009;302:1872-1879.
45. Centers for Disease Control and Prevention. Intensive-care patients with severe novel influenza A (H1N1) virus infection-Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-752.
46. O'Rourke PP, Crone RK, Vacanti JP, et al. Extracoporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study. Pediatrics 1989; 84:957-963. (Pubitemid 20003326)
47. Barlett RH, Roloff DW, Cornell RG, et al. Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatrics 1985;76:479-487. (Pubitemid 15248220)
48. Bifano EM, Hakanson DO, Hingre RV, Gross SJ. Prospective randomized controlled trial of conventional treatment or transport for ECMO in infants with persistent pulmonary hypertension (PPHN). Pediatr Res 1992;31:196A.
49. Extracorporeal Life Support Organization. ECLS Registry Report. Ann Arbor: University of Michigan. January 2004.
50. Goodman DM, Green TP. Extracorporeal life support for children with acute respiratory distress syndrome. In: Zwischenberger JB, Steinhorn RH, Bartlett RH, eds. ECMO: Extracorporeal Cardiopulmonary Support in Critical Care. Ann Arbor, Mich. Extracorporeal Life Support Organization 2000:451-460.
51. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure: A randomized prospective study. JAMA 1979;242:2193-2196. (Pubitemid 10195729)
52. Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;149:295-305. (Pubitemid 24068971)
53. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 2009;374:1351-1363.
54. Lim ME. The history of extracorporeal oxygenators. Anaesthesia 2006;61:984-995.
55. Hill JD, O'Brien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome): Use of the Bramson membrane lung. N Engl J Med 1972;286:629-634.
56. Bartlett RH. The development of prolonged extracorporeal circulation. In: Arensman RM, Cornish JD, eds. Extracorporeal Life Support. Boston. Blackwell Scientific Publications. 1993:31-41.
57. Gattinoni L, Pesenti A, Mascheroni D, et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 1986;256:8816.
58. Sidebotham D, McGeorge A, McGuinness S, et al. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults 1: Overview of extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth 2009;23:886-892.
59. Brogan TB, Thiagarajan RR, Rycus PT, et al. Extracorporeal membrane oxygenation in adults with severe respiratory failure: A multi-center database. Intensive Care Med 2009;35:2105-2114.
60. The Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA 2009; 302:1888-1895.
61. Freed DH, Henzler D, White CS, et al. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) infection in Canada. Can J Anesth 2010;57:240-247.
62. Roch A, Lepaul-Ercole R, Grisoli D, et al. Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: A prospective observational comparative study. Intensive Care Med 2010;36:1899-1905.
63. Berryman S. Extracorporeal membrane oxygenation in a Scottish intensive care unit. Nurs Crit Care 2010;15:262-268.
64. Robertson LC, Allen SH, Konamme SP, et al. The successful use of extra-corporeal membrane oxygenation in the management of a pregnant woman with severe H1N1 2009 influenza complicated by pneumonitis and adult respiratory distress syndrome. Int J Obstet Anesth 2010;19:443-447.
65. Oluyomi-Obi T, Avery L, Schneider C, et al. Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 influenza A. J Obstet Gynaecol Can 2010;32:443-447.
66. Peris A, Cianchi G, Biondi S, et al. Extracorporeal life support for management of refractory cardiac or respiratory failure: Initial experience in a tertiary center. Scand J Trauma Resusc Emerg Med 2010;18:28.
67. Buckley E, Sidebotham D, McGeorge A, et al. Extracorporeal membrane oxygenation for cardiorespiratory failure in four patients with pandemic H1N1 2009 influenza virus and secondary bacterial infection. Br J Anaesth 2010;104:326-329.
68. Grasselli G, Foti G, Patroniti N, et al. A case of ARDS associated with influenza A-H1N1 infection treated with extracorporeal respiratory support. Minerva Anestesiol 2009; 75:741-745.
69. Kao TM, Wang CH, Chen YC, et al. The first case of severe novel H1N1 influenza successfully rescued by extracorporeal membrane oxygenation in Taiwan. J Formos Med Assoc 2009;108:894-898.
70. Liong T, Lee KL, Poon YS, et al. The first novel influenza A (H1N1) fatality despite antiviral treatment and extracorporeal membrane oxygenation in Hong Kong. Hong Kong Med J 2009;15:381-384.
71. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection-Michigan. June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-752.
72. Wildschut ED, de Hoog M, Ahsman MJ, et al. Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support. PLoS One 2010;5:e10938.